{"organizations": [], "uuid": "f4b8eb6b0e81ee671024af271b3b61dde9994143", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-alexion-pharmaceuticals-says-ceo-l/brief-alexion-pharmaceuticals-says-ceo-ludwig-hantsons-total-fy-2017-compensation-was-15-3-mln-idUSFWN1RA0ZJ", "country": "US", "domain_rank": 408, "title": "BRIEF-Alexion Pharmaceuticals Says CEO Ludwig Hantson's Total FY 2017 Compensation Was $15.3 Mln", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-29T00:39:00.000+03:00", "replies_count": 0, "uuid": "f4b8eb6b0e81ee671024af271b3b61dde9994143"}, "author": "", "url": "https://www.reuters.com/article/brief-alexion-pharmaceuticals-says-ceo-l/brief-alexion-pharmaceuticals-says-ceo-ludwig-hantsons-total-fy-2017-compensation-was-15-3-mln-idUSFWN1RA0ZJ", "ord_in_thread": 0, "title": "BRIEF-Alexion Pharmaceuticals Says CEO Ludwig Hantson's Total FY 2017 Compensation Was $15.3 Mln", "locations": [], "entities": {"persons": [{"name": "ludwig hantson", "sentiment": "negative"}, {"name": "ludwig hant", "sentiment": "negative"}, {"name": "paul clancy", "sentiment": "none"}], "locations": [], "organizations": [{"name": "brief-alexion pharmaceuticals", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "alexion pharmaceuticals inc", "sentiment": "none"}, {"name": "alexion pharmaceuticals", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 28 (Reuters) - Alexion Pharmaceuticals Inc:\n* ALEXION PHARMACEUTICALS SAYS CEO LUDWIG HANTSONâ€™S TOTAL FY 2017 COMPENSATION WAS $15.3 MILLION - SEC FILING\n* ALEXION PHARMACEUTICALS SAYS CFO PAUL CLANCY'S TOTAL 2017 COMPENSATION WAS $11.4 MILLION - SEC FILING Source text: ( bit.ly/2uuGqo4 ) Further company coverage:\n ", "external_links": [], "published": "2018-03-29T00:39:00.000+03:00", "crawled": "2018-03-29T00:55:20.000+03:00", "highlightTitle": ""}